title: Should we exclude individuals from endoscopy based exclusively on the absence of alarm symptoms?
authors.forename: M
authors.initials: M
authors.lastname: Dinis-Ribeiro
authors.forename: H
authors.initials: H
authors.lastname: Lomba-Viana
authors.forename: R
authors.initials: R
authors.lastname: Silva
authors.forename: N
authors.initials: N
authors.lastname: Fernandes
authors.forename: N
authors.initials: N
authors.lastname: Abreu
authors.forename: C
authors.initials: C
authors.lastname: Brandão
authors.forename: L
authors.initials: L
authors.lastname: Moreira-Dias
authors.forename: A
authors.initials: A
authors.lastname: da Costa-Pereira
mesh_terms: D001707:Biopsy, Needle; D015331:Cohort Studies; D003937:Diagnosis, Differential; D004415:Dyspepsia / Q000175:diagnosis*; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology; D005757:Gastritis, Atrophic / Q000175:diagnosis*; D005773:Gastroscopy / Q000706:statistics & numerical data*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D010808:Physical Examination; D018570:Risk Assessment; D012720:Severity of Illness Index; D013274:Stomach Neoplasms / Q000175:diagnosis*